Knowing the possible side effects is part of feeling prepared. It gives you a way to describe what is happening and a plan for whom to contact, instead of trying to decide from an online comment whether a symptom is “normal.”
This overview uses current product information and FDA safety material. It is not a complete medication guide or an assessment of your personal risk. Keep the instructions for the exact prescription and ask your clinician to explain anything that is unclear.
One thing to keep with you
Have a contact plan before treatment begins. Severe symptoms should not be treated as proof that the medicine is working.
Stomach symptoms need context
Nausea, vomiting, diarrhea, constipation, and abdominal discomfort are among the common adverse effects described in Wegovy labeling. Common does not mean every severity is harmless. Persistent vomiting, inability to keep fluids down, or worsening symptoms deserve clinical attention because dehydration and other complications can occur.
Ask how the care team wants you to report symptoms and when the treatment plan needs review. Do not increase a dose, restart after a break, or add another medicine based on someone else’s experience.
Checked with: Wegovy: current prescribing information · MedlinePlus: semaglutide information
Bring the history that changes the plan
The Wegovy boxed warning concerns thyroid C-cell tumors observed in rodents, with the relevance to humans uncertain. Personal or family history of medullary thyroid carcinoma, or MEN 2, is a contraindication. This is more specific than saying every thyroid condition is the same issue.
Also discuss pancreatitis, gallbladder disease, significant stomach-emptying problems, kidney concerns, diabetic eye disease, pregnancy plans, and other medicines. Our introductory guide helps organize the appointment without turning a checklist into personal clearance.
Checked with: Wegovy: current prescribing information
Tell every relevant care team
Semaglutide can affect gastric emptying. Tell the team responsible for anesthesia or deep sedation about its use before a procedure; do not invent your own medication-holding schedule. Other medicines, especially some diabetes treatments, can change the risk of low blood sugar and may need clinician review.
The tablet and injection comparison also explains why administration instructions depend on the formulation. A daily tablet and a weekly injection should never be combined or swapped on the assumption that the ingredient name makes them interchangeable.
Checked with: Wegovy: current prescribing information · MedlinePlus: GLP-1 medicines
Know when reading should stop and help should begin
Seek prompt medical assessment for severe or persistent abdominal pain, repeated vomiting with dehydration, or other serious changes. Difficulty breathing, swelling of the face or throat, collapse, or another apparent emergency needs emergency care. The actual medication guide provides further warning signs.
If you may have taken too much or used the wrong amount, contact a medical professional or poison control promptly. FDA’s compounded-product dosing concern is one reason to clarify every measurement before use. A routine service message may not be monitored as an emergency channel.
Checked with: Wegovy: current prescribing information · FDA: compounded semaglutide dosing errors
Where we checked the facts
- Wegovy: current prescribing information
June 2026 label includes oral and injectable formulations with product-specific uses and instructions. Do not apply one formulation’s directions to another.
- MedlinePlus: semaglutide information
Patient medication information; the actual prescription and current product labeling govern use.
- MedlinePlus: GLP-1 medicines
General patient education about the medicine class, not individual eligibility advice.
- FDA: compounded semaglutide dosing errors
Reports involving measurement and conversion errors, including hospitalizations; no universal syringe-unit conversion is appropriate.
